Published in Medical Devices and Surgical Technology Week, November 21st, 2004
"The drug development process utilizes the parallel assessment of activity at a therapeutic target as well as absorption, distribution, metabolism, excretion, and toxicity properties of molecules," scientists in Michigan explained. "The development of novel, reliable, and inexpensive computational methods for the early assessment of metabolism and toxicity is becoming increasingly an important part of this process."
In the journal Drug Metabolism and Disposition, K.V. Balakin and colleagues at St. Joseph-based GeneGo, Inc. presented "a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.